Jules Stein Eye Institute, University of California, Los Angeles — Los Angeles, California

Jules Stein Eye Institute, University of California, Los Angeles is a clinical research site located in Los Angeles, California, United States 90095-7003.

Crixeo Clinical Trials Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Jules Stein Eye Institute, University of California, Los Angeles has participated in 2 clinical trials.

Therapeutic areas: Cytomegalovirus Retinitis, HIV Infections, Optic Atrophy.

Sponsors: Johns Hopkins Bloomberg School of Public Health, Quark Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angeles

Browse all research sites in California · View every site in Los Angeles

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Jules Stein Eye Institute, University of California, Los Angeles?

Jules Stein Eye Institute, University of California, Los Angeles has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Jules Stein Eye Institute, University of California, Los Angeles conducted?

Jules Stein Eye Institute, University of California, Los Angeles has 2 clinical trials on record. Their work covers Cytomegalovirus Retinitis, HIV Infections, Optic Atrophy.

Is Jules Stein Eye Institute, University of California, Los Angeles accredited by Crixeo Clinical Trials?

Jules Stein Eye Institute, University of California, Los Angeles has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Jules Stein Eye Institute, University of California, Los Angeles?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.